Brief biography of partner
Founded in 1900, the University of Birmingham (UoB) is a leading global, research-intensive institution and a founding member of the Russell Group of UK universities. Consistently ranked among the world’s top universities, UoB is recognised for excellence in teaching, research, and innovation across a wide range of disciplines.
The University has an extensive track record of participation in European and international research programmes, bringing expertise in engineering, computer science, health sciences, social sciences, and policy studies. It hosts cutting-edge research centres and institutes addressing major societal challenges, including security, resilience, and emerging technologies.
Through interdisciplinary collaboration and strong partnerships with industry, government, and international organisations, UoB delivers innovative solutions and evidence-based research that contribute to tackling global challenges.
Role in the project
The University of Birmingham leads the development of the OVA-GLY glycan recognition assay within Work Package 5 – Ovarian Cancer Liquid Biopsy Diagnostics. Drawing on its internationally recognised expertise in chemical and biomedical engineering, UoB is responsible for advancing a novel serum-based diagnostic tool that targets specific glycoproteins and glycans associated with ovarian cancer.